1. Wojtas, A.; Ciszewski, S. Epidemiologia bezsenności. [Epidemiology of insomnia.] Med. Forum. 2011, 8(3),79–83.
2. Wichniak, A.; Bieńkowski, P.; Dąbrowski, R.; Mastalerz-Migas, A.; Rymaszewska, J. Treatment of insomnia in older adults. Recommendations of the Polish Sleep Research Society, Polish Society of Family Medicine and the Polish Psychiatric Association. Psychiatr. Pol. 2023, 57, 495–516. DOI: 10.12740/PP/OnlineFirst/161597
3. Siemiński, M.; Skorupa, Ł.; Wiśniewska-Skorupa, K. Diagnostyka i terapia bezsenności w praktyce ogólnolekarskiej Część I: Epidemiologia, patomechanizm i diagnostyka bezsenności. [Diagnostics and therapy of insomnia in general practice. Part I: Epidemiology, pathomechanism and diagnostics of insomnia.] Forum Medycyny Rodzinnej 2018, 12, 242–251.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; American Psychiatric Association: Washington, DC, USA, 1994.
5. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed.; American Academy of Sleep Medicine: Darien, IL, USA, 2014.
6. Skalski, M. Insomnia – pathogenesis and treatment. COSMOS Probl. Biol. Sci. 2014, 63, 233-243.
7. Medycyna Praktyczna. Bezsenność. [Practical Medicine. Insomnia.] Available online: https://www.mp.pl/pacjent/psychiatria/bezsennosc/70349,bezsennosc (accessed on 17 January 2024).
8. Medycyna Praktyczna. Fizjologia snu. Available online: https://www.mp.pl/pacjent/psychiatria/bezsennosc/70378,fizjologia-snu (accessed on 20 January 2024).
9. Gackowski, M.; Mądra-Gackowska, K.; Kędziora-Kornatowska, K.; Koba, M. Farmakoterapia bezsenności u pacjentów w starszym wieku. [Pharmacotherapy for insomnia in older patients.] Geriatrics. 2019, 13, 90-96.
10. Foley, D.J.; Monjan, A.A.; Brown, S.L.; Simonsick, E.M.; Wallace, R.B.; Blazer, D.G. Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep. 1995, 18, 425-432. DOI: 10.1093/sleep/18.6.425
11. Ford, E.S.; Wheaton, A.G.; Cunningham, T.J.; Giles, W.H.; Chapman, D.P.; Croft, J.B. Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care survey 1999-2010. Sleep. 2014, 37, 1283-1293. DOI: 10.5665/sleep.3914
12. Nowicki, Z.; Grabowski, K.; Cubała, W.J.; Nowicka-Sauer, K.; Zdrojewski, T.; Rutkowski, M.; Bandosz, P. Prevalence of self-reported insomnia in general population of Poland. Psychiatr. Pol. 2016, 50, 165-173. DOI: 10.12740/PP/58771
13. Schlack, R.; Hapke, U.; Maske, U.; et al. Frequency and distribution of sleep problems and insomnia in the adult population in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt. 2013, 56, 740–748. DOI: 10.1007/s00103-013-1689-2
14. Leger, D.; Guilleminault, C.; Dreyfus, J.P.; et al. Prevalence of insomnia in a survey of 12,778 adults in France. J. Sleep Res. 2000, 9, 35–42. DOI: 10.1046/j.1365-2869.2000.00178.x
15. Pallesen, S.; Sivertsen, B.; Nordhus, I.H.; et al. A 10-year trend of insomnia prevalence in the adult Norwegian population. Sleep Med. 2014, 15, 173–179. DOI: 10.1016/j.sleep.2013.10.009
16. Walacik-Ufnal, E. Zastosowanie terapii poznawczo-behawioralnej w leczeniu bezsenności. [Cognitive behavioral therapy in the treatment of insomnia.] Psychiatry. 2015, 12, 90–98.
17. Wichniak, A.; Iwański, M.; Salbert, J. Diagnoza I leczenie bezsenności u osób starszych. [Diagnosis and treatment of insomnia in the elderly] General Practitioner 2023, 9(5), 272-278.
18. Abad, V.C.; Guilleminault, Ch. Diagnosis and treatment of sleep disorders: a brief review for clinicians. Dialogues Clin. Neurosci. 2003, 5, 371–388. DOI: 10.31887/DCNS.2003.5.4/vabad
19. Roth, T. Insomnia: Definition, Prevalence, Etiology, and Consequences. J. Clin. Sleep Med. 2007, 3, S7-S10.
20. Fernandez-Mendoza, J.; Vgontzas, A.N. Insomnia and Its Impact on Physical and Mental Health. Curr. Psychiatry Rep. 2013, 15, Art. No: 418. DOI: 10.1007/s11920-013-0418-8
21. Kamel, N.S.; Gammack, J.K. Insomnia in the elderly: cause, approach, and treatment. Am. J. Med. 2006, 119, 463-9. DOI: 10.1016/j.amjmed.2005.10.051
22. Sateia, M.J.; Buysse, D.J.; Krystal, A.D.; Neubauer, D.N.; Heald, J.L. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J. Clin. Sleep Med. 2017, 13, 307–349. DOI: 10.5664/jcsm.6470
23. Edinger, J.D.; Arnedt, J.T.; Bertisch, S.M.; Carney, C.E.; Harrington, J.J.; Lichstein, K.L.; Martin, J.L. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 2021, 17, 255-262. DOI: 10.5664/jcsm.8986
24. Patel, D.; Steinberg, J.; Patel, P. Insomnia in the Elderly: A Review. J. Clin. Sleep Med. 2018, 14, 1017–1024. DOI: 10.5664/jcsm.7172
25. Agravat, A. “Z”-hypnotics versus benzodiazepines for the treatment of insomnia. Prog. Neurol. Psychiatr. 2018, 22, 26–29. DOI:10.1002/pnp.502
26. Edinoff, A.N.; Wu, N.; Ghaffar, Y.T.; Prejean, R.; Gremillion, R.; Cogburn, M.; Chami, A,A.; Kaye, A.M.; Kaye, A.D. Zolpidem: Efficacy and Side Effects for Insomnia. Health Psychol. Res. 2021, 9, Art. No: 24927 DOI: 10.52965/001c.24927
27. Abad, V.C.; Guilleminault, C. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging. 2018, 35, 791-817. DOI: 10.1007/s40266-018-0569-8
28. Rösner, S.; Englbrecht, C.; Wehrle, R.; Hajak, G.; Soyka, M. Eszopiclone for insomnia. Cochrane Database of Syst. Rev. 2018, 10(10), Art. No: CD010703. DOI: 10.1002/14651858.CD010703.pub2
29. Soyka, M.; Wild, I.; Caulet, M.; Leontiou, C.; Lugoboni, F.; Hajak, G. Long-term use of benzodiazepines in chronic insomnia: a European perspective, Front. Psychiatry. 2023, 14, Art. No: 1212028. DOI: 10.3389/fpsyt.2023.1212028
30. Karsten, J.; Hagenauw, L.A.; Kamphuis, J.; Lancel, M. Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial. J. Psychopharmacol. 2017, 31, 327–337. DOI: 10.1177/0269881116681399
31. Anderson, S.L.; Vande Griend, J.P. Quetiapine for insomnia: A review of the literature. Am. J. Health-Syst. Pharm. 2014, 71(5), 394-402. DOI:10.2146/ajhp130221
32. Riemann, D.; Baglioni, C.; Bassetti, C.; Bjorvatn, B.; Dolenc Groselj, L.; Ellis, J.G.; i wsp. European guideline for the diagnosis and treatment of insomnia. J. Sleep Res. 2017, 26, 675–700. DOI: 10.1111/jsr.12594
33. Awgul, S.; Uździcki, A.; Żelazny, P.; Pawlik, A. Pharmacotherapy of insomnia – currently existing therapies and new trends in research. Farmacja współczesna [Contemporary pharmacy[]. 2018, 11, 207-214.
34. Berezińska, M.; Lorenc-Duda, A.; Zawilska, J.B. Ramelteon – lek nasenny nowej generacji. [Ramelteon – a new-generation sleep drug.] Farm. Pol. 2010, 66(3), 173-178.
35. Altinyazar, V.; Kiylioglu, N. Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature. Ther. Adv. Psychopharmacol. 2016, 6, 263-268. DOI: 10.1177/2045125316646064
36. Herring, W.J.; Connor, K.M.; Snyder, E.; Snavely, D.B.; Zhang, Y.; Hutzelmann, J.; Matzura-Wolfe, D.; Benca, R.M.; Krystal, A.D.; Walsh, J.K.; Lines, C.; Roth, T.; Michelson, D. Suvorexant in patients with insomnia: Pooled analyses of three-month data from phase-3 randomized controlled clinical trials. J. Clin. Sleep Med. 2016, 12, 1215–1225. DOI: 10.5664/jcsm.6116
37. Muehlan, C.; Roch, C.; Vaillant, C.; Dingemanse, J. "The orexin story and orexin receptor antagonists for the treatment of insomnia." J. Sleep Res. 2023, 32, Art. No: e13902. DOI: 10.1111/jsr.13902